Bestyrelsesmedlem i Coloplast Jørgen Tang-Jensen har onsdag samlet solgt 2453 aktier.
Bestyrelsesmedlem i Coloplast Jørgen Tang-Jensen har onsdag solgt aktier for godt 2 mio. kr. i selskabet.
Det fremgår af en meddelelse fra Coloplast.
Jørgen Tang-Jensen har samlet solgt 2453 aktier til en gennemsnitlig pris af 816,08 kr., hvilket svarer til en kursværdi af 2.001.844,24 kr.
Sydbank: Coloplast-regnskab med både plusser og minusser
Coloplast-chef glad for nyt solidt regnskab: "Alle forretninger tager markedsandele"
Coloplast afgør sin urologiforretnings skæbne inden året er omme
Associate Director / Director of Global Drug Safety - Y-mAbs
Head of CMC at Afyx Therapeutics A/S
Scientific Publication Manager - Zealand Pharma
Associate Director Preclinical Development – Y-mAbs
Senior Data Manager - Y-mAbs Therapeutics
Global Project Director – Orphazyme
Device Design Control Specialist - Zealand Pharma
Senior Programming Manager - Genmab
Global Medical Director Translational Medicine
Director Product Supply - Y-mAbs Therapeutics
Director, Head of Global Healthcare Compliance - Leo Pharma
Supply Chain Manager - Y-mAbs Therapeutics
Director of Business Planning & Forecasting – OrphaZyme
Kommunikationskonsulent til Medicoindustrien
Senior Manager, Facilities Operations - Zealand Pharma
Country Manager Denmark
Drug Substance Specialist - Zealand Pharma
Senior Facility Operations Manager - Genmab
Principal Statistician - OrphaZyme
Senior Programming Manager, Clinical Data Standards - Genmab
Senior Manager / Director of Regulatory Affairs – make your mark on LCM and CMC - Y-mAbs Therapeutics
Regulatory Affairs Assistant - Orifarm
Sponsor Oversight Lead - Genmab
